These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1260 related articles for article (PubMed ID: 7699630)
21. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures. Dagfinrud H; Vollestad NK; Loge JH; Kvien TK; Mengshoel AM Arthritis Rheum; 2005 Feb; 53(1):5-11. PubMed ID: 15696569 [TBL] [Abstract][Full Text] [Related]
22. Assessing back pain: does the Oswestry Disability Questionnaire accurately measure function in ankylosing spondylitis? O'Shea FD; Riarh R; Anton A; Inman RD J Rheumatol; 2010 Jun; 37(6):1211-3. PubMed ID: 20395642 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. Claudepierre P; Sibilia J; Goupille P; Flipo RM; Wendling D; Eulry F; Clerc D; Berthelot JM; Vergne P; Roudot-Thoraval F; Larget-Piet B; Chevalier X J Rheumatol; 1997 Oct; 24(10):1954-8. PubMed ID: 9330938 [TBL] [Abstract][Full Text] [Related]
24. Computer-administered bath ankylosing spondylitis and Quebec Scale outcome questionnaires for low back pain: agreement with traditional paper format. Bent H; Ratzlaff CR; Goligher EC; Kopec JA; Gillies JH J Rheumatol; 2005 Apr; 32(4):669-72. PubMed ID: 15801023 [TBL] [Abstract][Full Text] [Related]
25. An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, the Health Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions. Schefte DB; Hetland ML Rheumatology (Oxford); 2010 Jan; 49(1):99-104. PubMed ID: 19920097 [TBL] [Abstract][Full Text] [Related]
26. Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis. Fernández-Sueiro JL; Willisch A; Pértega-Díaz S; Tasende JA; Fernández-López JC; Villar NO; Galdo F; Blanco FJ Arthritis Care Res (Hoboken); 2010 Jan; 62(1):78-85. PubMed ID: 20191494 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a quantitative scoring of enthesitis in ankylosing spondylitis. Kaya A; Ozgocmen S; Kamanli A; Aydogan R; Yildirim A; Ardicoglu O J Clin Rheumatol; 2007 Dec; 13(6):303-6. PubMed ID: 18176136 [TBL] [Abstract][Full Text] [Related]
28. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R; Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001 [TBL] [Abstract][Full Text] [Related]
29. Costs and quality of life of patients with ankylosing spondylitis in Canada. Kobelt G; Andlin-Sobocki P; Maksymowych WP J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660 [TBL] [Abstract][Full Text] [Related]
30. Mental health status and leisure-time physical activity contribute to fatigue intensity in patients with spondylarthropathy. Da Costa D; Dritsa M; Ring A; Fitzcharles MA Arthritis Rheum; 2004 Dec; 51(6):1004-8. PubMed ID: 15593104 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J; Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973 [TBL] [Abstract][Full Text] [Related]
32. Is disease severity in ankylosing spondylitis genetically determined? Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700 [TBL] [Abstract][Full Text] [Related]
33. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Taylor WJ; Harrison AA Arthritis Rheum; 2004 Jun; 51(3):311-5. PubMed ID: 15188312 [TBL] [Abstract][Full Text] [Related]
34. Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG). El Miedany Y; Youssef S; Mehanna A; Shebrya N; Abu Gamra S; El Gaafary M Clin Rheumatol; 2008 May; 27(5):605-12. PubMed ID: 18180979 [TBL] [Abstract][Full Text] [Related]
35. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Ariza-Ariza R; Hernández-Cruz B; Navarro-Sarabia F Arthritis Rheum; 2003 Aug; 49(4):483-7. PubMed ID: 12910553 [TBL] [Abstract][Full Text] [Related]
36. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413 [TBL] [Abstract][Full Text] [Related]
37. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Tubach F; Pham T; Skomsvoll JF; Mikkelsen K; Bjørneboe O; Ravaud P; Dougados M; Kvien TK Arthritis Rheum; 2006 Dec; 55(6):960-3. PubMed ID: 17139643 [TBL] [Abstract][Full Text] [Related]